secwatch.observer — SEC 8-K summary
======================================

Issuer:     ULTRALIFE CORP (ULBI)
CIK:        0000875657
Form:       8-K
Filed at:   2025-04-01T23:59:59+00:00
Accession:  0001437749-25-010359
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultralife Q4 GAAP EPS $0.01 vs $0.17 YoY; sales $43.9M; backlog $102.2M
-----------------------------------------------------------------------

- Q4 sales $43.9M, down from $44.5M YoY; Battery & Energy +11.7%, Communications -55.1%.
- GAAP EPS $0.01 ($0.2M net income) vs $0.17 ($2.9M) in Q4 2023; adjusted EPS also $0.01.
- Operating income $1.5M including $1.1M one-time acquisition costs; adjusted EBITDA $3.9M.
- Full-year sales $164.5M (+3.7%); GAAP EPS $0.38 vs $0.44; adjusted EBITDA $16.5M.
- Backlog and high-confidence orders $102.2M at year-end 2024 vs $78.0M at Q3 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875657/000143774925010359/0001437749-25-010359-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875657/000143774925010359/ulbi20250331_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-010359

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer